SCHEMBL5052302

SCHEMBL5052302

NC(=O)C(S)(c1ccccc1)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.48
SLC22A2 O15244 1/20 0.48
SLC22A1 O15245 1/20 0.48
PGR P06401 1/20 0.48
THRB P10828 1/20 0.48
ADRB3 P13945 1/20 0.48
OPRK1 P41145 1/20 0.48
PMP22 Q01453 1/20 0.48
KCNH2 Q12809 1/20 0.48
PDE3A Q14432 1/20 0.48
SLC47A1 Q96FL8 1/20 0.48
CYP3A4 P08684 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 4/20 0.42
MAPT P10636 1/20 0.42
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28637349 0.90 L3MBTL1 (0.50) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL5056708 0.84 AHR (0.54) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL5052363 0.80 MAPT (0.56) BLMPMP22KCNH2CYP3A4TSHR
SCHEMBL5054998 0.75 SMN1; SMN2 (0.39) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL11473546 0.74 MAPT (0.40) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL11721606 0.72 SMN1; SMN2 (0.43) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL11471392 0.72 NPC1 (0.40) SMN1; SMN2KMT2AMAPTLMNAKCNN4
SCHEMBL8283520 0.72 MAPT (0.52) BLMSLC22A2SLC22A1PGRTHRB
SCHEMBL2465434 0.72 SMN1; SMN2 (0.50) BLMSLC22A2SLC22A1PGRTHRB
Urea SCHEMBL28161295 0.71 SMN1; SMN2 (0.54) BLMSLC22A2SLC22A1PGRTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119456-A1 Substituted Thiazoleacetic Acid as Crth2 Ligands 7TM PHARMA A/S (DK) 2008-05-22 US disclosed
US-4379158-A Antisecretory imidazole amidine compounds, composition and method of use YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1983-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119456-A1 Substituted Thiazoleacetic Acid as Crth2 Ligands HRH1, HRH2, HRH3 BLM 3183/4885SLC22A2 1742/4885SLC22A1 1637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.